Blossom's psychedelic research recap for January

Blossom is a website providing a number of great resources in service to its vision to make "information about the potential of psychedelics available to all stakeholders to help speed up the psychedelic transition from trials to practice." Here is their Psychedelic Recap for January with its description "Researchers in the field of psychedelics hit the ground running at the turn of the new year. January brought with it the largest published clinical trial with psilocybin to date. While ketamine was shown to effectively treat patients with alcohol use disorder, the same can’t be said for PTSD. A host of reviews provide food for thought on a range of psychedelics and their mechanism of action."

For more psychedelic news and research, visit the psychedelic health professional network homepage.

Previous
Previous

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science

Next
Next

Looking ahead to a psychedelic 2022